Crossmark

A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition

Crossref DOI link: https://doi.org/10.1186/s40360-020-00416-3

Published Online: 2020-06-23

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheah, Kit Yee http://orcid.org/0000-0001-6397-5735
Mah, Kar Yee

Pang, Lai Hui

Ng, Shi Min

Wong, Jia Woei

Tan, Siew Siew

Tan, Hong Zhe

Yuen, Kah Hay
License Information

Text and Data Mining valid from 2020-06-23

Version of Record valid from 2020-06-23
More Information

Article History

Received: 25 March 2019

Accepted: 19 May 2020

First Online: 23 June 2020

Ethics approval and consent to participate

: This study was approved by the Medical Research and Ethics Committee (MREC), Ministry of Health Malaysia, with the registration number NMRR-17-1266-36001. All subjects were informed about the aim of the study, study procedures and restrictions as well as side-effects that may occur from participation. Voluntary participation and freedom to withdraw from the study at any time were duly conveyed to them and written informed consent from all subjects were obtained prior to commencement of the study.

: Written consent to publish from subjects was obtained during informed consent process where they were informed that no personal information will appear in any report or publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below